Dai on the tip of the tongue
Release time:
2021-12-13
"food color, sex also " , people in daily life are often full of love and yearning for beautiful things, one food and one drink are all hot and looking forward to life. In my spare time, I had the honor to visit Xishuangbanna. In addition to experiencing the strong exotic customs of Xishuangbanna, I was also conquered by the local distinctive Dai flavor.
Dai flavor, as the name implies, is the Dai diet. The most characteristic of Dai flavor is Dai flavor hand pilaf, because it includes almost all Dai dishes.
The most striking thing about Dai-flavor hand-held rice is that all the dishes are tiled like peacocks. It is not like a home-cooked dish served on the table, but placed in a sieve woven of bamboo, which is covered with washed fresh banana leaves. The emerald green banana leaves emit a fragrance, and the green in the eyes flows straight in the heart, giving people a fresh and refined feeling. All kinds of seasonal fruits, colorful glutinous rice and various Dai dishes form "peacock " gorgeous feathers, and a lifelike peacock head ornament is placed in the middle. The whole banquet is shaped like a peacock, and diners are surprised again and again. The Dai people regard the peacock as a mascot, and this concept should also be reflected in their diet.
A Dai-flavor hand-held rice mainly includes ten kinds of dishes: cold dishes, dried dishes, fried dishes, barbecue, meat dishes, desserts, soups, fruits, glutinous rice and Dai-flavor pickled cabbage rice noodles. Common ones are Dai-flavored nan mi platter, cold mix, hand-torn dried beef, fried pork skin, chicken leg tendons choked with oil, citronella grilled fish, baked banana heart, baked minced eggplant, charcoal grilled three-line meat, citronella grilled chicken, Dai-flavored pickled cabbage rice noodles, pineapple rice, seasonal vegetable soup, fruit and glutinous rice platter, etc.
Each dish has its own characteristics. Citronella grilled chicken and grilled fish are mixed with the unique fragrance of citronella. The chicken skin is slightly browned and crisp, and the meat is fresh and chewy. The fish retains the tender and delicious quality of the tilapia meat, and tastes mixed with the unique sweetness of the fish. The nan mi platter is made up of various refreshing vegetables such as white cucumber, lettuce, water celery, raw cabbage, boiled cauliflower, etc., supplemented by Dai-specific tomato nan mi, peanut nan mi and millet spicy lemon dipped in three kinds of dipping water, sweet and sour, fresh and spicy, which can satisfy the taste buds of all diners. Coupled with fried pork skin, crispy and delicious, the more you chew, the more you chew, the more you chew, the more you taste. Pineapple rice is to empty the whole pineapple core, then add some white sugar to the purple glutinous rice cooked in advance and the pineapple meat taken out, stir well and steam in the pan. The steamed pineapple rice is attractive in color, glutinous aroma mixed with the sweet and sour of pineapple, and has a unique flavor.
In short, Dai flavor is unique because of its unique materials, sour and spicy taste, light taste and appetizing taste. Each dish has distinctive features. Friends from afar must try Dai flavor hand-held rice when they come to Yunnan.
(Qi Jianmei)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31